Sponsor:
Lazaros Lekakis
Code:
NCT05260957
Conditions
Refractory Non-Hodgkin Lymphoma
Relapsed Non Hodgkin Lymphoma
Aggressive Non-Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Mosunetuzumab
Polatuzumab
CAR-T Cell Therapy
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations